Header Logo

Connection

Michael Rosenblatt to Risk Assessment

Back to Details
This is a "connection" page, showing publications Michael Rosenblatt has written about Risk Assessment.
Michael Rosenblatt
Connection Strength
0.031
Risk Assessment
  1. Rosenblatt M. Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspective. J Bone Miner Res. 2003 Jun; 18(6):1142-5.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.